Affinage

CUX2

Homeobox protein cut-like 2 · UniProt O14529

Length
1486 aa
Mass
161.7 kDa
Annotated
2026-04-28
40 papers in source corpus 17 papers cited in narrative 17 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

CUX2 is a homeodomain transcription factor with three Cut repeat domains that governs neural progenitor cell-cycle exit, cortical neuron differentiation, dendritic morphogenesis, and DNA damage repair. CUX2 binds DNA rapidly but transiently and functions primarily as a transcriptional repressor, directly regulating target promoters including Neurod, p27Kip1, ADCY1, and KDM5B to control proliferation and differentiation in the SVZ, spinal cord, and cortical layer II–III neurons, where it also shapes dendritic branching and spine maturation through transcriptional control of chromatin remodeling genes Xlr3b/Xlr4b (PMID:15656993, PMID:18033766, PMID:18223201, PMID:20510857). Beyond its canonical transcription factor role, the CUX2 Cut repeat domains directly stimulate OGG1-mediated oxidative base excision repair, and CUX2 function in L2/3 cortical neurons confers resilience to DNA damage–induced death during neuroinflammation (PMID:26221032, PMID:41922773). In liver, CUX2 acts as a sex-specific transcriptional regulator by competing with HNF6 for DNA binding to control sexually dimorphic gene expression (PMID:22966202, PMID:26218442).

Mechanistic history

Synthesis pass · year-by-year structured walk · 12 steps
  1. 1996 High

    Establishing CUX2 as a DNA-binding transcription factor with a defined domain architecture (three Cut repeats plus a homeodomain) resolved the basic molecular identity of the gene product and its capacity for sequence-specific DNA recognition.

    Evidence In vitro DNA binding assay with GST fusion protein containing C-terminal Cut repeat and homeodomain, binding NCAM promoter oligonucleotides

    PMID:8798433

    Open questions at the time
    • Full-length protein binding properties not characterized
    • Transcriptional output (activation vs. repression) not determined
    • In vivo DNA targets unknown
  2. 2004 High

    Demonstrating that CUX2 makes rapid but transient DNA contacts—unlike CUX1—and functions exclusively as a transcriptional repressor established a fundamental biochemical distinction between the two CUX family paralogs.

    Evidence In vitro DNA binding kinetics with purified Cut repeat fusion proteins; transcriptional reporter assays in NIH3T3 cells

    PMID:15656993

    Open questions at the time
    • In vivo relevance of rapid/transient binding kinetics unresolved
    • Whether CUX2 can activate transcription in other cell types not tested
  3. 2007 High

    Showing that CUX2 controls cell-cycle exit of SVZ intermediate progenitors cell-autonomously—independently of CUX1—established a non-redundant developmental function in cortical neurogenesis.

    Evidence Cux2 knockout mouse; BrdU double-labeling cell-cycle re-entry assays; Cux1/Cux2 double-knockout epistasis

    PMID:18033766

    Open questions at the time
    • Direct transcriptional targets mediating cell-cycle exit in SVZ not identified
    • Mechanism by which CUX2 restrains proliferation not molecularly defined
  4. 2008 High

    Identifying Neurod and p27Kip1 as direct CUX2 transcriptional targets via ChIP provided a molecular mechanism linking CUX2 DNA binding to cell-cycle exit and neuroblast differentiation in the spinal cord.

    Evidence In vivo chromatin immunoprecipitation; loss- and gain-of-function in knockout and transgenic mice

    PMID:18223201

    Open questions at the time
    • Whether CUX2 activates or represses these promoters context-dependently not fully resolved
    • Cofactors mediating CUX2 transcriptional activity at these targets unknown
  5. 2008 High

    The finding that CUX1 and CUX2 are redundantly required for Reelin-expressing cortical interneuron specification revealed a shared function distinct from CUX2's non-redundant role in SVZ progenitors.

    Evidence Cux1/Cux2 double-knockout mouse; immunohistochemistry for Reelin in cortical layers II–IV

    PMID:18327765

    Open questions at the time
    • Whether CUX2 directly regulates Reelin transcription not shown
    • Mechanism distinguishing redundant versus non-redundant CUX1/CUX2 functions unknown
  6. 2010 High

    Establishing CUX2 as an intrinsic regulator of dendritic branching, spine maturation, and synapse formation in layer II–III neurons—partly through Xlr3b/Xlr4b—connected its transcriptional activity to post-mitotic neuronal morphogenesis and circuit function.

    Evidence Cux2 knockout and knockdown; dendritic morphology quantification; electrophysiology; working memory behavioral testing; molecular target identification

    PMID:20510857

    Open questions at the time
    • How Xlr3b/Xlr4b chromatin remodeling controls spine maturation not mechanistically defined
    • Whether dendritic defects are reversible post-developmentally unknown
  7. 2012 High

    Demonstrating that CUX2 is a sex-specific transcriptional regulator in female liver that activates female-biased and represses male-biased genes expanded its functional repertoire beyond the nervous system.

    Evidence Adenoviral CUX2 overexpression in male liver; siRNA knockdown in female liver; CUX2 ChIP-seq; transcriptomic analysis

    PMID:22966202

    Open questions at the time
    • Upstream signals conferring female-specific CUX2 expression not fully defined
    • Whether CUX2 liver function is relevant to metabolic physiology not tested
  8. 2015 High

    Showing that CUX2 Cut repeats directly stimulate OGG1 glycosylase/AP lyase activity revealed a non-transcriptional function in oxidative DNA base excision repair, establishing a dual role for CUX2 in both transcription and genome maintenance.

    Evidence In vitro reconstitution with purified OGG1 and CUX2 Cut repeat domains; CUX2 knockdown in embryonic cortical neurons; ectopic expression rescue

    PMID:26221032

    Open questions at the time
    • Whether CUX2 participates in BER in vivo at endogenous expression levels not shown with structural detail
    • Physical basis of CUX2-OGG1 interaction not structurally resolved
  9. 2015 High

    Establishing that CUX2 competes with HNF6 for overlapping genomic binding sites provided a concrete mechanism for how CUX2 modulates sex-biased hepatic transcription through competitive DNA occupancy.

    Evidence In vitro EMSA; ChIP-seq cistrome overlap analysis; cell-based reporter assays

    PMID:26218442

    Open questions at the time
    • Dynamic in vivo competition kinetics not characterized
    • Whether STAT5 chromatin remodeling is upstream or parallel to CUX2/HNF6 competition unresolved
  10. 2022 Medium

    Identification of CUX2-CASP physical interaction and the demonstration that CUX2 loss enhances glutamatergic transmission and seizure susceptibility linked CUX2 to excitatory synapse regulation and epilepsy-relevant phenotypes.

    Evidence Co-immunoprecipitation; Cux2 knockout mouse electrophysiology; kainate seizure model; human CUX2 variant localization studies

    PMID:35581205

    Open questions at the time
    • CUX2-CASP interaction not validated by reciprocal co-IP or in vivo proximity labeling
    • Mechanism by which CUX2 restrains excitatory neuron number unknown
    • Causal role of human CUX2 variants in epilepsy not established by genetic segregation
  11. 2022 Medium

    Direct transcriptional activation of ADCY1 and KDM5B by CUX2 extended the catalog of direct target promoters and linked CUX2 to disease-relevant signaling in glioma and breast cancer contexts.

    Evidence ChIP and dual-luciferase reporter assays; loss- and gain-of-function in glioma and breast cancer cell lines; xenograft models

    PMID:35881915 PMID:36242624

    Open questions at the time
    • CUX2 activation function at these promoters contrasts with its originally defined repressor role—context-dependent cofactors not identified
    • Relevance of these axes to normal physiology unclear
  12. 2026 High

    Demonstrating that CUX2 is essential for L2/3 cortical neuron resilience to DNA damage during neuroinflammation unified its transcription factor and DNA repair functions into a neuroprotective mechanism with disease relevance.

    Evidence Cux2 knockout mice in demyelination and pan-cortical inflammation models; in vitro interferon-γ treatment; DNA damage quantification and neuronal survival assays

    PMID:41922773

    Open questions at the time
    • Relative contribution of transcriptional versus direct OGG1-stimulatory functions to neuroprotection not dissected
    • Whether CUX2-dependent resilience extends to other neurodegenerative conditions not tested

Open questions

Synthesis pass · forward-looking unresolved questions
  • The structural basis of CUX2's rapid/transient DNA binding, the cofactors determining whether CUX2 activates versus represses transcription in different cell types, and the relative contributions of its transcriptional versus DNA repair functions to neuronal survival remain unresolved.
  • No high-resolution structure of CUX2 bound to DNA
  • Cofactors switching CUX2 from repressor to activator not identified
  • Relative contribution of BER stimulation versus transcriptional regulation to neuroprotection not separated genetically

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0003677 DNA binding 7 GO:0140110 transcription regulator activity 5 GO:0140097 catalytic activity, acting on DNA 1
Localization
GO:0005634 nucleus 5
Pathway
R-HSA-1266738 Developmental Biology 5 R-HSA-1640170 Cell Cycle 2 R-HSA-73894 DNA Repair 2
Partners
CASPCUX1HNF6OGG1

Evidence

Reading pass · 17 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1996 CUX2 protein contains three Cut repeat domains and one homeodomain, and a GST fusion protein containing the C-terminal Cut repeat and homeodomain exhibits sequence-specific DNA binding to oligonucleotides derived from the NCAM gene promoter. In vitro DNA binding assay with GST fusion protein; structural/domain analysis The Journal of biological chemistry High 8798433
2004 Purified CUX2 Cut repeat fusion proteins (CR1CR2, CR2CR3HD, CR3HD) bind DNA with similar sequence specificity as corresponding CUX1 domains but with much more rapid kinetics; the full-length CUX2 protein makes rapid but transient interactions with DNA, in contrast to CUX1. CUX2 functions exclusively as a transcriptional repressor in NIH3T3 cells, unlike CUX1 which can activate or repress. In vitro DNA binding kinetics assays with purified fusion proteins; transcriptional reporter assays in NIH3T3 cells Gene High 15656993
2007 CUX2 controls cell cycle exit of SVZ intermediate neuronal precursors in a cell-autonomous manner; Cux2-deficient mice show excessive SVZ precursor proliferation and increased upper layer neuron number. CUX2 function is independent of CUX1 in controlling SVZ proliferation, as shown in Cux1−/−; Cux2−/− double mutants. Knockout mouse analysis, cell cycle re-entry assays (BrdU double labeling), overexpression studies, genetic epistasis (double mutant) Cerebral cortex High 18033766
2008 CUX2 directly binds the promoters of Neurod and p27(Kip1) in vivo (shown by chromatin immunoprecipitation), and regulates cell-cycle progression of spinal cord neural progenitors; loss-of-function reduces Neurod and p27(Kip1) activity while gain-of-function induces high levels of both, linking CUX2 transcriptional activity to cell-cycle exit and neuroblast formation. Chromatin immunoprecipitation (ChIP) in vivo; loss-of-function (knockout mice) and gain-of-function (transgenic mice) with phenotypic analysis Development High 18223201
2008 CUX1 and CUX2 together are required for the specification of Reelin-expressing cortical interneurons; Cux1−/−; Cux2−/− double mutant mice completely lack Reelin expression in cortical layers II-IV, while single mutants are unaffected, demonstrating redundant roles. Genetic epistasis via double-knockout mouse analysis; immunohistochemistry for Reelin Developmental neurobiology High 18327765
2009 CUX2 functions downstream of Notch signaling in regulating dorsal spinal cord interneuron formation; Notch signaling regulates Cux2 expression, and Cux2 loss-of-function impairs interneuron formation, placing CUX2 as a downstream mediator of Notch in this context. Loss-of-function mouse studies; Notch pathway manipulation establishing epistatic relationship Development Medium 19542352
2010 CUX2 is an intrinsic regulator of dendritic branching, spine development, and synapse formation in layer II-III cortical neurons; Cux2 knockout mice show reduced dendritic arbors, abnormal spine maturation, and reduced synaptic function correlated with working memory deficits. CUX2 partly controls spine number and maturation through direct transcriptional regulation of chromatin remodeling genes Xlr3b and Xlr4b. Knockout and knockdown studies; morphological analysis; electrophysiology; molecular target identification; behavioral testing (working memory) Neuron High 20510857
2012 CUX2 functions as a sex-specific transcriptional regulator in female liver, activating female-biased genes and repressing male-biased genes; CUX2 chromatin binding is preferentially enriched near repressed genes and at sites of male-biased DNase hypersensitivity and male-enriched STAT5 binding regions. Adenoviral overexpression in male liver; siRNA knockdown in female liver; ChIP-seq for CUX2 binding; transcriptomic analysis Molecular and cellular biology High 22966202
2014 CUX2 has distinct effects on apical versus basal dendritic compartments: modulation of CUX2 levels predominantly affects apical dendrite development, while CUX1 predominantly affects basal dendrites, as determined by in vivo loss- and gain-of-function studies in layer II-III cortical neurons. In vivo loss-of-function and gain-of-function analysis; dendritic morphology quantification Developmental neurobiology Medium 25059644
2015 CUX2 Cut repeat domains stimulate OGG1 (8-oxoguanine DNA glycosylase 1) activity in vitro: they increase OGG1 binding to 8-oxoguanine-containing DNA and stimulate both its glycosylase and AP lyase activities. CUX2 knockdown in embryonic cortical neurons and other cell types increases oxidative DNA damage and delays repair, while ectopic expression of CUX2 Cut repeats accelerates repair. In vitro enzymatic assay with purified proteins; CUX2 knockdown in neurons and cell lines; ectopic expression; DNA damage quantification The Journal of biological chemistry High 26221032
2015 CUX2 competes with HNF6 for DNA binding at shared genomic sites in liver chromatin; CUX2 inhibits HNF6-mediated transcriptional regulation of CYP2C11 and CYP2C12 promoters, with ~90% of CUX2 binding sites also bound by HNF6. Competition for DNA binding was demonstrated by in vitro EMSA and validated in vivo by global cistrome analysis. In vitro EMSA; cell-based transfection reporter assays; ChIP-seq cistrome analysis Molecular endocrinology High 26218442
2019 Lmx1a transcription factor directly activates a conserved intronic CUX2 enhancer in the cortical hem; Lmx1a-binding sites are required for enhancer activity in vivo, and mis-expression of Lmx1a in hippocampal progenitors expands CUX2 enhancer activity ectopically. In vitro transcription reporter assays; in vivo enhancer analysis; bioinformatics; mis-expression experiments Development Medium 30770393
2019 Lhx2 acts as a transcriptional activator of Cux2 through a conserved 220 bp enhancer element (Cux2-E1) that controls cortical layer II-IV-specific expression; identified by comparative genome analysis, in vivo reporter assays, and immunohistochemistry in Cux2-mCherry transgenic mice. BAC transgenic reporter mice; in vivo reporter assay; comparative genomic analysis; immunohistochemistry Biochemical and biophysical research communications Medium 31708105
2022 CUX2 and CASP (a CUX1 short isoform) physically interact with each other and are co-expressed in excitatory neurons of the entorhinal cortex. CUX2 knockout mice show increased excitatory neuron numbers in the entorhinal cortex and enhanced glutamatergic synaptic transmission to the hippocampus, with increased seizure susceptibility to kainate. CUX2 variants associated with temporal lobe epilepsy show abnormal subcellular localization in human cell culture. Co-immunoprecipitation (CUX2-CASP interaction); knockout mouse electrophysiology; cell culture localization studies; targeted sequencing Scientific reports Medium 35581205
2022 CUX2 binds the ADCY1 promoter (demonstrated by ChIP assay and dual-luciferase reporter) to enhance ADCY1 transcription, and this CUX2/ADCY1 axis suppresses glioma cell proliferation, migration, and invasion. ChIP assay; dual-luciferase reporter assay; loss- and gain-of-function in glioma cells; xenograft mouse model Experimental brain research Medium 36242624
2022 CUX2 transcriptionally activates KDM5B expression (shown by ChIP and dual-luciferase reporter), and KDM5B in turn represses SOX17 through histone demethylation, forming a CUX2/KDM5B/SOX17 regulatory axis that promotes breast cancer malignant phenotypes. ChIP assay; dual-luciferase reporter; siRNA knockdown; Western blot; xenograft model Endocrinology Medium 35881915
2026 CUX2 function in L2/3 excitatory neurons is essential for resilience to DNA damage during neuroinflammation; Cux2 loss-of-function increases selective vulnerability of L2/3 neurons in mouse models of demyelination and pan-cortical inflammation, and interferon-γ causes elevated reactive oxygen species leading to DNA damage-mediated death of CUX2+ neurons in vitro. Knockout mouse models (demyelination, inflammation); in vitro interferon-γ treatment; DNA damage quantification; loss-of-function with defined neuronal survival phenotype Nature High 41922773

Source papers

Stage 0 corpus · 40 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2004 Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II-IV of the cerebral cortex. The Journal of comparative neurology 414 15452856
2010 Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex. Neuron 244 20510857
2004 Dynamics of Cux2 expression suggests that an early pool of SVZ precursors is fated to become upper cortical layer neurons. Cerebral cortex (New York, N.Y. : 1991) 189 15238450
2007 Cux-2 controls the proliferation of neuronal intermediate precursors of the cortical subventricular zone. Cerebral cortex (New York, N.Y. : 1991) 96 18033766
2015 Lineage Tracing Using Cux2-Cre and Cux2-CreERT2 Mice. Neuron 71 25996136
1996 Primary structure, neural-specific expression, and chromosomal localization of Cux-2, a second murine homeobox gene related to Drosophila cut. The Journal of biological chemistry 69 8798433
2012 Impact of CUX2 on the female mouse liver transcriptome: activation of female-biased genes and repression of male-biased genes. Molecular and cellular biology 63 22966202
2008 Cux2 (Cutl2) integrates neural progenitor development with cell-cycle progression during spinal cord neurogenesis. Development (Cambridge, England) 57 18223201
2014 Cux1 and Cux2 selectively target basal and apical dendritic compartments of layer II-III cortical neurons. Developmental neurobiology 50 25059644
2015 CUX2 protein functions as an accessory factor in the repair of oxidative DNA damage. The Journal of biological chemistry 47 26221032
2008 Cux-1 and Cux-2 control the development of Reelin expressing cortical interneurons. Developmental neurobiology 45 18327765
2006 Expression of Cux-1 and Cux-2 in the developing somatosensory cortex of normal and barrel-defective mice. The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology 44 16419078
2011 The transcription factor Cux2 marks development of an A-delta sublineage of TrkA sensory neurons. Developmental biology 39 21945863
2004 Biochemical characterization of the mammalian Cux2 protein. Gene 37 15656993
2003 Dynamic expression of murine Cux2 in craniofacial, limb, urogenital and neuronal primordia. Gene expression patterns : GEP 35 12971989
2015 Cross Talk Between GH-Regulated Transcription Factors HNF6 and CUX2 in Adult Mouse Liver. Molecular endocrinology (Baltimore, Md.) 33 26218442
2003 CDP-2,3-Di-O-geranylgeranyl-sn-glycerol:L-serine O-archaetidyltransferase (archaetidylserine synthase) in the methanogenic archaeon Methanothermobacter thermautotrophicus. Journal of bacteriology 32 12562787
2018 The epilepsy phenotypic spectrum associated with a recurrent CUX2 variant. Annals of neurology 23 29630738
2005 Linkage disequilibrium mapping of bipolar affective disorder at 12q23-q24 provides evidence for association at CUX2 and FLJ32356. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 22 15389760
2014 Cux2 acts as a critical regulator for neurogenesis in the olfactory epithelium of vertebrates. Developmental biology 21 24512687
2018 A recurrent de novo CUX2 missense variant associated with intellectual disability, seizures, and autism spectrum disorder. European journal of human genetics : EJHG 20 29795476
2009 Cux2 functions downstream of Notch signaling to regulate dorsal interneuron formation in the spinal cord. Development (Cambridge, England) 20 19542352
2014 Cux2 activity defines a subpopulation of perinatal neurogenic progenitors in the hippocampus. Hippocampus 19 25252086
2022 CUX2 deficiency causes facilitation of excitatory synaptic transmission onto hippocampus and increased seizure susceptibility to kainate. Scientific reports 12 35581205
2021 Adult Upper Cortical Layer Specific Transcription Factor CUX2 Is Expressed in Transient Subplate and Marginal Zone Neurons of the Developing Human Brain. Cells 12 33671178
2019 Cux2 expression regulated by Lhx2 in the upper layer neurons of the developing cortex. Biochemical and biophysical research communications 11 31708105
2001 CUX2, a potential regulator of NCAM expression: genomic characterization and analysis as a positional candidate susceptibility gene for bipolar disorder. American journal of medical genetics 11 11353453
2020 CUX2, BRAP and ALDH2 are associated with metabolic traits in people with excessive alcohol consumption. Scientific reports 10 33093602
2019 Lmx1a drives Cux2 expression in the cortical hem through activation of a conserved intronic enhancer. Development (Cambridge, England) 9 30770393
2018 CUX2 functions as an oncogene in papillary thyroid cancer. OncoTargets and therapy 9 30636884
2022 CUX2/KDM5B/SOX17 Axis Affects the Occurrence and Development of Breast Cancer. Endocrinology 7 35881915
2019 Cux2 refines the forelimb field by controlling expression of Raldh2 and Hox genes. Biology open 7 30651234
2016 Cux2 serves as a novel lineage marker of granule cell layer neurons from the rhombic lip in mouse and chick embryos. Developmental dynamics : an official publication of the American Association of Anatomists 7 27198720
2022 Novel Variant Expands the Clinical Spectrum of CUX2-Associated Developmental and Epileptic Encephalopathies. Frontiers in genetics 5 35846140
2019 Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population. Pharmacogenetics and genomics 5 30720667
2023 Androgen-Dependent Expression of CUX2 mRNA in the Pig Liver Is Associated with That of Drug Metabolizing Enzymes and Drug Transporters. Biological & pharmaceutical bulletin 4 36858577
2022 CUX2 prevents the malignant progression of gliomas by enhancing ADCY1 transcription. Experimental brain research 2 36242624
2026 DNA damage burden causes selective CUX2 neuron loss in neuroinflammation. Nature 0 41922773
2026 Expansion of outer cortical CUX2 neurons requires adaptations for DNA repair. Nature 0 41922774
2025 A novel frameshift CUX2 variant in a patient with epilepsy and global developmental delay: Phenotypic and genotypic expansion. European journal of medical genetics 0 41344425